Macrogen, Inc. (KOSDAQ: 038290)

Market Cap	169.64B
Revenue (ttm)	131.02B
Net Income (ttm)	-20.48B
Shares Out	9.98M
EPS (ttm)	-2,053.78
PE Ratio	n/a
Forward PE	35.42
Dividend	300.00 (1.76%)
Ex-Dividend Date	n/a

Volume	17,115
Open	17,040
Previous Close	17,010
Day's Range	17,040 - 17,370
52-Week Range	15,470 - 26,700
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Macrogen

Macrogen, Inc. provides precision medicine and bio-engineering healthcare services in Korea and internationally. It offers personal healthcare services, including disease prediction and wellness genetic, and DTC genetic testing services; MyPETGENE, a genetic testing service for companion animals; clinical services, such as precision medicine, genetic testing for cancer risk, NGS-based genetic panel lab, and GCLP services; and single cell expert services comprising single cell multi-omics and spatial transcriptome analysis, and single cell (In S...

• Industry: Commercial Physical and Biological Research
• Founded: 1997
• Employees: 516
• Stock Exchange: KOSDAQ
• Ticker Symbol: 038290

Financial Performance

In 2023, Macrogen's revenue was 132.80 billion, a decrease of -4.19% compared to the previous year's 138.62 billion. Losses were -16.81 billion, -24.44% less than in 2022.